FYERS
Zydus Lifesciences1188.10
-52.50 (-4.23%)

Zydus Lifesciences Share Price

1188.10-52.50 (-4.23%)
+21.10% past 1 Year

Corporate filings & documents

Announcements

Press Release
7 hours ago
Investor presentation
7 hours ago
Appointment of statutory auditors pursuant to mandatory auditor rotation
7 hours ago
Outcome of Board Meeting held on November 4 2026
7 hours ago
Unaudited Financial Results for the quarter and half year ended on September 30 2026
7 hours ago
Update on acquisition of API business
2 days ago
Changes in Senior Management team
4 days ago
Changes in Senior Management team
4 days ago
The newspaper publication of notice of loss of share certificate of the Company published in the Financial Express English and Gujarati editions both on October 30 2026.
5 days ago
The newspaper publication of notice of loss of share certificate of the Company published in the Financial Express English and Gujarati editions both on October 30 2026.
5 days ago
Q2 FY27 post results earning call details
1 week ago
Q2 FY27 post results earning call details
1 week ago
Zylidac Bio and Prolific Machines Partner to Scale Prolifics Next-Generation Biologics Manufacturing Platform to GMP Production.
2 weeks ago
Zylidac Bio and Prolific Machines Partner to Scale Prolifics Next-Generation Biologics Manufacturing Platform to GMP Production.
2 weeks ago
Zydus receives USFDA approval for Estradiol and Levonorgestrel Transdermal System eligible for 180-day CGT exclusivity.
2 weeks ago
Zydus receives USFDA approval for Estradiol and Levonorgestrel Transdermal System eligible for 180-day CGT exclusivity.
2 weeks ago
Zydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 inter alia to consider and approve unaudited financial results for the quarter / half year ended on September 30 2026.
2 weeks ago
Zydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 inter alia to consider and approve unaudited financial results for the quarter / half year ended on September 30 2026.
2 weeks ago
ESG Rating
2 weeks ago
ESG Rating
2 weeks ago
Zydus Sunshine Lifesciences signs agreement with Board of Investment Sri Lanka to establish a pharmaceutical manufacturing facility in Sri Lanka.
2 weeks ago
Zydus Sunshine Lifesciences signs agreement with Board of Investment Sri Lanka to establish a pharmaceutical manufacturing facility in Sri Lanka.
2 weeks ago
USFDA Inspection
3 weeks ago
USFDA Inspection
3 weeks ago
Zydus and Formycon: FYB206 Becomes First Publicly Announced Keytruda Biosimilar Accepted for Review by UDFDA.
3 weeks ago
Zydus and Formycon: FYB206 Becomes First Publicly Announced Keytruda Biosimilar Accepted for Review by UDFDA.
3 weeks ago
Zydus Therapeutics Presents New Post Hoc Analysis of Phase 3 EPICS-III Trial at ACG 2026 Showing Greater Biochemical Response With Investigational Saroglitazar Compared to Placebo Across Geographic Subgroups in PBC.
3 weeks ago
Zydus Therapeutics Presents New Post Hoc Analysis of Phase 3 EPICS-III Trial at ACG 2026 Showing Greater Biochemical Response With Investigational Saroglitazar Compared to Placebo Across Geographic Subgroups in PBC.
3 weeks ago
Certificate under regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended on September 30 2026.
4 weeks ago
Certificate under regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended on September 30 2026.
4 weeks ago
Zydus MSN partner to Launch First Generic of Adempas (Riociguat Tablets) in the U.S.
4 weeks ago
Zydus MSN partner to Launch First Generic of Adempas (Riociguat Tablets) in the U.S.
4 weeks ago
Extension of date of closing
1 month ago
Extension of date of closing
1 month ago
USFDA inspection concludes at Zydus manufacturing plant at SEZ II Ahmedabad.
1 month ago
USFDA inspection concludes at Zydus manufacturing plant at SEZ II Ahmedabad.
1 month ago
Intimation of Trading Window Closure
1 month ago
Intimation of Trading Window Closure
1 month ago
USFDA inspection of pharmacovigilance and post marketing system concludes at Zydus USA Office with nil observations.
1 month ago
USFDA inspection of pharmacovigilance and post marketing system concludes at Zydus USA Office with nil observations.
1 month ago
Newspaper publication of Notice of loss of share certificate of the Company published in the Financial Express English and Gujarati editions both on September 24 2026.
1 month ago
Newspaper publication of Notice of loss of share certificate of the Company published in the Financial Express English and Gujarati editions both on September 24 2026.
1 month ago
Newspaper publication of Notice of opening of Special Window for transfer and dematerialization of physical securities published in the Financial Express English and Gujarati editions both on September 22 2026.
1 month ago
Newspaper publication of Notice of opening of Special Window for transfer and dematerialization of physical securities published in the Financial Express English and Gujarati editions both on September 22 2026.
1 month ago
Credit Rating
1 month ago
Credit Rating
1 month ago
The Company is going to participate in J.P. Morgan India Conference 2026 on September 21 2026.
1 month ago
The Company is going to participate in J.P. Morgan India Conference 2026 on September 21 2026.
1 month ago
Newspaper publication of Notice of loss of share certificate of the Company published in the Financial Express English and Gujarati editions both on September 9 2026.
1 month ago
Newspaper publication of Notice of loss of share certificate of the Company published in the Financial Express English and Gujarati editions both on September 9 2026.
1 month ago

Annual reports

FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17
FY 2015-16

Concalls & investor presentations

Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Nov 2025
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Nov 2024
ConcallPresentation
Aug 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Aug 2022
ConcallPresentation
May 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Oct 2021
ConcallPresentation
Aug 2021
ConcallPresentation
May 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Nov 2020
ConcallPresentation

Zydus Lifesciences Ltd Share Price Today

The Zydus Lifesciences Ltd share price today is ₹1152.8. During the trading session, the Zydus Lifesciences Ltd share price opened at ₹1151 and recorded an intraday high of ₹1158 and a low of ₹1123.7. Last closing price was ₹1162. Over the past 52 weeks, the Zydus Lifesciences Ltd share price has ranged between ₹835.5 and ₹1232.1. The current Zydus Lifesciences Ltd stock price reflects real-time market activity based on executed trades on the exchange.